Acurx Pharmaceuticals Inc.

ACXP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.33

-$0.06 (-4.32%)

At close: Sep 21, 2026, 4:00 PM ET

$1.31

-$0.02 (-1.50%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	7.56M	3.71M	7.47M	9.11M	12.96M	3.18M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	48.42K	51.13K	129.16K	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	7.69M	3.86M	7.71M	9.38M	13.25M	3.22M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	7.69M	3.86M	7.71M	9.38M	13.25M	3.22M
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	16.63K
Other Current Liabilities	2.41M	537.63K	716.31K	542.9K	508.34K	317.07K
Total Current Liabilities	2.42M	3.24M	3.04M	2.06M	843.91K	472.56K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	49.88K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	49.88K
Total Liabilities	2.42M	3.24M	3.04M	2.06M	843.91K	522.43K
Total Debt	n/a	n/a	n/a	n/a	n/a	66.5K
Book Value	5.27M	615.12K	4.67M	7.32M	12.41M	2.7M
Book Value Per Share	3.51	0.72	7.37	13.53	24.30	5.45
Common Stock	2.35K	17.03K	14.47K	11.63K	10.22K	16.5M
Retained Earnings	-75.29M	-67.32M	-53.22M	-38.64M	-26.55M	-13.8M
Comprehensive Income	n/a	n/a	n/a	-38.64M	-26.55M	-13.8M
Shareholders Equity	5.27M	615.12K	4.67M	7.32M	12.41M	2.7M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a